Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
09/2005
09/01/2005US20050192293 Vanilloid receptor VR1 modulators; pain, inflammation, traumatic injury, autoimmune disease; compounds are pyridine subsituted at 2 position with an amido-, sulfoamido- or thioamide-substituted (N-hetero)aryl ring
09/01/2005US20050192291 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
09/01/2005US20050192287 Substituted benzazoles and methods of their use as inhibitors of Raf kinase
09/01/2005US20050192286 Ligands of melanocortin receptors and compositions and methods related thereto
09/01/2005US20050192277 Histamine-3 receptor antagonists; 4-(2-{2-[(2R)-2-methyl-1-pyrrolidinyl]ethyl}-1-benzofuran-4-yl)benzonitrile; acute myocardial infarction, asthma, psychological disorders, gastrointestinal disorders, inflammation, jet lag, cancer, septic shock, Tourette's syndrome, neurodegenerative disorders
09/01/2005US20050191571 Polymeric charge transport compositions for organophotoreceptors
09/01/2005US20050191570 Organophotoreceptor with charge transport compositions
09/01/2005DE102004008141A1 Guanidinverbindungen und ihre Verwendung als Bindungspartner für 5-HT5-Rezeptoren Guanidine compounds and their use as binding partners for 5-HT5 receptors
09/01/2005DE102004006808A1 Substituierte 4,5,6,7-Tetrahydro-benzothiazol-2-ylamin-Verbindungen Substituted 4,5,6,7-tetrahydro-benzothiazol-2-ylamine compounds
09/01/2005CA2556480A1 Pyrimidine derivatives and use thereof as agricultural and horticultural fungicides
09/01/2005CA2555812A1 3-3-di-substituted-oxindoles as inhibitors of translation initiation
09/01/2005CA2555402A1 Bipyridyl amides as modulators of metabotropic glutamate receptor-5
09/01/2005CA2554888A1 Rosiglitazone phosphate and polymorphic forms
09/01/2005CA2554774A1 Novel heterocyclic compound
09/01/2005CA2554686A1 Compounds
09/01/2005CA2554310A1 Benzamide derivatives and their use as glucokinase activating agents
09/01/2005CA2498644A1 Anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (no) production
08/2005
08/31/2005EP1569040A2 Organophotoreceptor with charge transport compositions
08/31/2005EP1569039A2 Polymeric charge transport compositions for organophotoreceptors
08/31/2005EP1568692A1 (pyridin-4-yl)alkyl-amides as TNF-alpha production inhibitors
08/31/2005EP1568367A1 Compounds effecting glucokinase
08/31/2005EP1567597A1 Process for the production of meso-substituted cyanine dyes
08/31/2005EP1567532A1 Oxazolidinone and / or isoxazoline derivatives as antibacterial agents
08/31/2005EP1567525A2 Substituted piperazine compounds and their use as fatty acid oxidation inhibitors
08/31/2005EP1567524A1 Thia-epothilone derivatives for the treatment of cancer
08/31/2005EP1567523A1 Indolyl derivatives
08/31/2005EP1567522A1 Pyrimidine compounds
08/31/2005EP1567520A2 Quinolines and nitrogenated derivatives thereof and their use as antibacterial agents
08/31/2005EP1567506A2 Cyanoguanidines and cyanoamidines as erbb2 and egfr inhibitors
08/31/2005EP1567493A1 Phenyl substituted piperidine compounds for use as ppar activators
08/31/2005EP1567491A2 Compounds for inhibition of hiv infection by blocking hiv entry
08/31/2005EP1567490A2 Anti-sickling agents
08/31/2005EP1567489A1 Pyrrolidin-2-one derivatives as inhibitors of thrombin and factor xa
08/31/2005EP1567488A1 Hydroxyethylamine derivatives for the treatment of alzheimer's disease
08/31/2005EP1567112A2 Novel chemical compounds
08/31/2005EP1478437B1 Acc inhibitors
08/31/2005EP1395576B1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
08/31/2005EP1237875B1 Substituted imidazole neuropeptide y y5 receptor antagonists
08/31/2005EP1140809B1 New biphenyl and biphenyl-analogous compounds as integrin antagonists
08/31/2005EP0882718B1 Benzimidazole derivatives
08/31/2005CN1662529A Thiazole derivatives as phosphodiesterase IV inhibitors
08/31/2005CN1662528A Piperazine benzothiazoles as agents for the treatment of cerebral ischemic disorders or cns disorders
08/31/2005CN1662527A Pyrrolidinium derivatives as antagonists of M3 muscarinic receptors
08/31/2005CN1662514A Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them
08/31/2005CN1662508A Compounds, compositions and methods
08/31/2005CN1662236A Inhibitors of histone deacetylase
08/31/2005CN1661483A Organophotoreceptor with charge transport compositions
08/31/2005CN1661482A Polymeric charge transport compositions for organophotoreceptors
08/31/2005CN1660839A Chemical compounds
08/31/2005CN1660824A 2-substitution-5-(3, 4, 5-trialkoxy phenyl)-1, 3, 4-ramification of thiadiazoles and preparation method and biological activity
08/31/2005CN1660821A Oxodiethylenediamine derivative and light stabilized composition
08/31/2005CN1660815A Cyclic amine derivatives and their use as drugs
08/31/2005CN1660083A Method of using benzenesulphoamides that are cyclooxygenase-2-inhibitors in the treatment and prevention of neoplasia
08/31/2005CN1216874C (Hetero) aryl-substituted heterocyclic enaminones, production thereof and use thereof as herbicides, acaricides and insectivides
08/31/2005CN1216867C 2-amino-nicotinamide derivative sand their use as VEGF-receptor tyrosine kinase inhibitors
08/30/2005US6936626 Retinoic acid mimetic anilides
08/30/2005US6936616 Pyrimidine matrix metalloproteinase inhibitors
08/30/2005US6936611 Serine protease inhibitors
08/30/2005US6936600 Oxidoreductase enzyme inhibitors such as (R)-1-[4-(2-methyl-4-phenyl-5,8-dihydro-6H-pyrido[3,4-d]pyrimidin-7-yl)-pyrimidin-2-yl-ethanol, used as antidiabetic agents
08/25/2005WO2005077945A2 Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
08/25/2005WO2005077944A1 Pyrimidine derivatives for use as vanilloid receptor ligands and their use in the treatment of pain
08/25/2005WO2005077943A1 1 , 3 - dioxane derivatives and analogues thereof useful in the treatment of i.a. obesity and diabetes
08/25/2005WO2005077938A1 Vanilloid receptor ligands and their use in treatments
08/25/2005WO2005077926A2 Benzofuran and benzothiophene derivatives useful for the treatment of cardiovascular disease
08/25/2005WO2005077924A1 Substituted 4,5,6,7-tetrahydro-benzothiazol-2-ylamine compounds
08/25/2005WO2005077922A2 Process for the preparation of substituted triazole compounds
08/25/2005WO2005077900A1 Bicyclic amide derivatives
08/25/2005WO2005077897A1 Substituted azetidine compounds, their preparation and use as medicaments
08/25/2005WO2005077124A2 Compounds and compositions as lxr modulators
08/25/2005WO2005076990A2 Process for preparing 2-aminothiazole-5-carboxamides useful as kinase inhibitors
08/25/2005WO2005058813A3 Thiodiazolidinedione, oxazolidinedione and diazolidinedione derivatives and their use as antidiabetic agents
08/25/2005WO2005011601A3 6-menbered heteroaryl compounds for the treatment of neurodegenerative disorders
08/25/2005WO2005010154A3 7 and 8 membered heterocyclic cyclopentyl benzylamide modulators of chemokine receptor activity
08/25/2005US20050187390 Bicyclic heteroaryl derivatives
08/25/2005US20050187387 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor
08/25/2005US20050187277 Protein tyrosine phosphatase inhibitors; diseases including type I and type II diabetes, cancer, autoimmune diseases, AIDS; imidazole, oxazole and thiazole derivatives; e.g. 4-(4-(2,4-dichloro-phenyl)-2-(2-(3'-methanesulfonyl-biphenyl-4-yl)-(E)-vinyl)-imidazol-1-ylmethyl)-benzoic acid
08/25/2005US20050187272 Enzyme inhibitor on NO-synthase enzymes; treating STROKE, NEURODEGENERATIVE DISEASES, preventing ISCHEMIC OR HEMORRAGIC CARDIAC OR CEREBRAL INFARCTIONS; inhibiting lipidic peroxidation
08/25/2005US20050187270 16-Halogen-epothilone derivatives, method for producing them and their pharmaceutical use
08/25/2005US20050187266 2-Methyl-2-{3-[({[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]carbonyl}amino)methyl]phenoxy}propanoic acid; polycystic ovarian syndrome; polycystic obesity; dietetics; hypoglycemic agents; antilipemic and - cholesterol agents; hypertriglyceridemia; insulin resistance; metabolic disorders; PPAR modulators
08/25/2005US20050187261 For hepatitis C; histone deacetylase inhibitors, anticarcinogenic agents; N-hydroxy-4-{[(benzofuran-, benzothiophen-, or indol-)-2-ylcarbonylamino]alkoxy}benzamides; amidation of a benzoic acid, benzoate, benzoyl halide with hydroxyamine
08/25/2005US20050187258 Hydrogenation of precursors to thiazolidinedione antihyperglycemics
08/25/2005US20050187242 9-[4-[4-[[2-(2,2,2-trifluoroethoxy)benzoyl]amino]-1-piperidinyl]butyl]-N-(2,2,2-trifluoroethyl)-9H-fluorene-9-carboxamide; non-steroidal modulator of the glucocorticoid receptor, AP-1, and/or NF- kappa B activity, obesity, diabetes, inflammatory and immune diseases
08/25/2005US20050187236 Nitrogen-containing aromatic derivatives
08/25/2005US20050187208 Substituted Azetidine compounds, their preparation and use as medicaments
08/25/2005US20050187194 fructose 1,6-bisphosphatase (FBPase) inhibitors for diabetic complications, hyperlipidemia, hypertension, arteriosclerosis, macroangiopathy; 2-amino-5-isobutyl-4-{2-[5-(N,N'-bis((S)-1-ethoxycarbonyl)ethyl)phosphonamido]furanyl}thiazole
08/25/2005US20050187110 Novel herbicides
08/25/2005DE102004006142A1 Neutrale und kationische Naphthalinderivate und diese Verbindungen enthaltende Färbemittel für Keratinfasern Neutral and cationic naphthalene derivatives and compositions containing these compounds stains for keratin fibers
08/25/2005CA2556565A1 Substituted azetidine compounds, their preparation and use as medicaments
08/25/2005CA2556239A1 Vanilloid receptor ligands and their use in treatments
08/25/2005CA2555825A1 Process for the preparation of substituted triazole compounds
08/25/2005CA2555817A1 1 , 3 - dioxane derivatives and analogues thereof useful in the treatment of i.a. obesity and diabetes
08/25/2005CA2555685A1 Pyrimidine derivatives for use as vanilloid receptor ligands and their use in the treatment of pain
08/25/2005CA2555595A1 Substituted 4,5,6,7-tetrahydrobenzothiazol-2-ylamine compound
08/25/2005CA2555291A1 Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
08/25/2005CA2554378A1 Bicycloamide derivative
08/24/2005EP1566378A1 Isoindoline derivative
08/24/2005EP1565461A2 Antibacterial substituted cyanomethyl(ene)piperidinophenyl oxazolidinones, process for their preparation, and pharmaceutical compositions containing them
08/24/2005EP1565459A2 Heteroarylsulfonylmethyl hydroxamic acids and amides and their use as protease inhibitors
08/24/2005EP1565455A1 Indolyl pyrazinone derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
08/24/2005EP1565452A2 3-substituted-6-aryl pyridines as ligands of c5a receptors
1 ... 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 ... 628